Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects

By Kohn Y.   Ebstein R.P.   Heresco-Levy U.   Shapira B.   Nemanov L.   Gritsenko I.   Avnon M.   Lerer B.  

European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. : 39-43

Elsevier

Access to resources Recommend Favorite

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients

By Gunes Arzu   Scordo Maria   Jaanson Peeter   Dahl Marja-Liisa  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 479-484

Springer Publishing Company

Access to resources Recommend Favorite

Modulation of the clozapine structure increases its selectivity for the dopamine D 4 receptor

By Liegeois J.-F.   Bruhwyler J.   Damas J.   Rogister F.   Masereel B.   Geczy J.   Delarge J.  

European Journal of Pharmacology, Vol. 273, Iss. 3, 1995-02 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Further evidence for clozapine as a dopamine D 1 receptor agonist

By Salmi P.   Ahlenius S.  

European Journal of Pharmacology, Vol. 307, Iss. 1, 1996-06 ,pp. : 27-31

Elsevier

Access to resources Recommend Favorite

D2 dopamine receptor gene polymorphism: paroxetine and social functioning in posttraumatic stress disorder

By Lawford B.R.   McD. Young   Noble E.P.   Kann B.   Arnold L.   Rowell J.   Ritchie T.L.  

European Neuropsychopharmacology, Vol. 13, Iss. 5, 2003-10 ,pp. : 313-320

Elsevier

Access to resources Recommend Favorite